Action on Smoking and Health surveys found 19% of 940 UK adults, and 14% of a New Zealand sample, used cigarettes to try to quit vaping. Both figures count quit attempts and leave open how many people stayed on cigarettes.
Reality
- Evidence45
- Adoption
- Insufficient
- Hype gap+35
- Incentives55
- Confidence45
DEA proposed in July to temporarily place 7-OH above a potency threshold in Schedule I, and nearly 36,000 public comments came in by Sept. 10. Experts agree kratom needs guardrails but split on where the line belongs.
Reality
- Evidence62
- Adoption
- Insufficient
- Hype gap+10
- Incentives60
- Confidence55
Intismeran autogene met both primary endpoints in a 1,137-patient melanoma trial. Every dose is built from one tumour's sequence, which turns approval into a question about process, not product.
Perspective Coverage
3 publishers
- Builder
- Builder 38%
- Operator
- Operator 42%
- Investor
- Investor 20%
Reality
- Evidence40
- Adoption5
- Hype gap+40
- Incentives75
- Confidence55
The United States is in its worst measles year since 1991. The figure on the federal counter is one death, marked subject to change, while Pennsylvania officials describe four deaths among unvaccinated people.
Reality
- Evidence55
- Adoption
- Insufficient
- Hype gap+10
- Incentives
- Insufficient
- Confidence50
United Therapeutics is sponsoring the first xenotransplant clinical trial. Its first patient got a 10-edit pig kidney at NYU Langone in November. The longest a gene-edited pig kidney has worked in a person is 271 days, against years or decades for a human donor organ.
Reality
- Evidence52
- Adoption31
- Hype gap+22
- Incentives72
- Confidence44
Meta has a hearing aid cleared as software and priced as a paid unlock on frames the wearer already owns. For the buyer that turns a medical purchase into a subscription-or-one-time decision.
Perspective Coverage
3 publishers
- Builder
- Builder 30%
- Operator
- Operator 37%
- Investor
- Investor 33%
Reality
- Evidence56
- Adoption15
- Hype gap+24
- Incentives74
- Confidence58
Meta's new VR glasses weigh about 100 grams, cost $1,299.99 and depend on a pocket puck rated for up to three hours of video playback. Zuckerberg said Meta will build fewer VR devices and ship them only on a breakthrough.
Reality
- Evidence38
- Adoption34
- Hype gap+32
- Incentives84
- Confidence46
The FDA will accept methods other than animal testing for drug and biologic safety determinations when it judges them appropriate, and the agency decides for itself what appropriate means.
Reality
- Evidence57
- Adoption
- Insufficient
- Hype gap+34
- Incentives64
- Confidence55
Securities staff now have an agreed route to the FDA's nonpublic record of a company's regulatory interactions and inspections. They can use it during a routine filing review, before any investigation is open.
Reality
- Evidence58
- Adoption
- Insufficient
- Hype gap+5
- Incentives65
- Confidence50
At Boulder Care, patients reporting kratom use went from 3% of new admissions last September to 14% in August. Two providers now describe the withdrawal in opioid terms, with no trial evidence to dose against.
Reality
- Evidence52
- Adoption48
- Hype gap+14
- Incentives62
- Confidence55
A Seeking Alpha analyst initiated coverage on GH Research at Buy after the company resolved the FDA clinical hold on GH001, and the note rests its competitive case on dosing time and fewer clinic visits than SPRAVATO.
Reality
- Evidence18
- Adoption
- Insufficient
- Hype gap+38
- Incentives62
- Confidence46
Alibaba's DAMO Academy put RADAR's training code and pretrained checkpoints under Apache 2.0 on September 18, a day after the Science paper. The 146 in the coverage counts radiological findings, cancers among them.
Reality
- Evidence70
- Adoption20
- Hype gap+20
- Incentives70
- Confidence62
A City of Hope team reports catching stage 1 and 2 pancreatic cancer from a three-marker blood score. The trial does not settle what a positive means in the high-risk groups a screening programme would enrol first.
Reality
- Evidence57
- Adoption8
- Hype gap+33
- Incentives63
- Confidence61
ZBeats' second FDA clearance this year moves ZBPro Diagnostic out of Holter-only labeling and into 14-day patch recordings. Adoption now turns on which recorders the software is cleared to read.
Reality
- Evidence55
- Adoption15
- Hype gap+25
- Incentives70
- Confidence55
Montana's first right-to-try authorization, a daily antihistamine plus an hour of proprietary sound for hearing loss, came from a privately run board created by Niklas Anzinger, a longevity investor who helped draft the law.
Reality
- Evidence55
- Adoption20
- Hype gap+40
- Incentives80
- Confidence55
A shop on Bedford Avenue sells injectable peptides next to the gum. WIRED bought four kinds, paid a startup to have them tested, and got back a negative on every label with no answer about what was in the vials.
Reality
- Evidence60
- Adoption45
- Hype gap+20
- Incentives65
- Confidence55
The Swedish company's headset beat a sham device on remission at 10 weeks in a 174-person trial. In the US it is prescription-only and cash-pay, at $2,200 for the first course and $325 a month after that.
Reality
- Evidence55
- Adoption35
- Hype gap+15
- Incentives78
- Confidence50
Nearly 13,000 reported cases were tied to recalled iceberg lettuce grown in central Mexico. Federal officials still cannot say how sewage contaminated enough food to sicken that many people.
Reality
- Evidence58
- Adoption80
- Hype gap+15
- Incentives48
- Confidence57
Berkeley banned sugary drink and snack displays at the register in March 2021. A Lancet Public Health analysis of 71 stores reports soda and small-package candy sales down where compliance was highest, while total candy sales did not fall.
Reality
- Evidence62
- Adoption38
- Hype gap+24
- Incentives58
- Confidence55
Emmanuel Mignot and Masashi Yanagisawa reached the same wakefulness peptide from opposite directions. The drug class that followed now holds one narcolepsy approval and a much larger set of untested hopes.
Reality
- Evidence78
- Adoption52
- Hype gap+12
- Incentives40
- Confidence74
Earlier coverage
- A 90-day inactivity timer closed a CAPA that never got a root cause review
Build · September 10, 2026 · 1 publisher
- ARPA-H puts up to $9.5 million behind testing whether an agent can adjust heart-failure care
Build · September 10, 2026 · 1 publisher
- Per-span citations mean your document store's version history is now part of the audit trail
Build · September 10, 2026 · 1 publisher
- Implicity raises more in one round than in its first nine years combined
Invest · September 9, 2026 · 1 publisher
- FDA foreign food inspections are running at 53% of their fiscal 2024 pace
Invest · September 5, 2026 · 1 publisher
- A child psychiatrist counts four academic centers and no clozapine prescriber
Science · September 4, 2026 · 1 publisher
- Circular puts an FDA-cleared ECG and tap-to-pay on the same finger
Product · September 3, 2026 · 1 publisher
- Washington takes the Carolina Principles to the G20 as its answer to binding AI rules
Product · September 1, 2026 · 1 publisher
- Growth-hormone peptides' best evidence comes from a 400-person HIV trial of just one drug, tesamorelin
Science · September 1, 2026 · 1 publisher
- Migraine prevention guidelines elevate CGRP drugs after a 14-year gap
Science · August 31, 2026 · 2 publishers
- A RAS inhibitor wins FDA approval in metastatic pancreatic cancer at $39,800 a month
Science · August 31, 2026 · 1 publisher
- Veradermics' 500% run prices a hair-loss launch still more than a year away
Invest · August 29, 2026 · 1 publisher
- Generation Lab recruits longevity influencers into a private cohort for a drug it won't name
Product · August 27, 2026 · 1 publisher
- The FDA lets one phlebotomist supervise three autonomous blood-draw robots at once
Build · August 27, 2026 · 1 publisher
- Summer's 17,000 cyclosporiasis cases move produce verification onto the buyer's books
Leadership · August 27, 2026 · 1 publisher
- Software picks the 34 neoantigens in Moderna and Merck's cancer vaccine
Science · August 27, 2026 · 1 publisher
- FDA caps the new blood draw robot at three machines per phlebotomist
Product · August 27, 2026 · 1 publisher
- UCLH's surgical AI earns its world first by annotating the endoscope feed
Product · August 27, 2026 · 1 publisher
- Cigna's $200M AI savings projection runs to about 2.4 basis points of a year's revenue
Invest · August 27, 2026 · 1 publisher
- The next DSM will name biology it cannot yet measure
Science · August 26, 2026 · 1 publisher
- Eight Sleep needs the FDA to turn a $2,999 mattress cover into a billable device
Invest · August 24, 2026 · 1 publisher
- Detection got faster than tracing, and the produce buyer now owns the recall
Leadership · August 22, 2026 · 1 publisher
- FDA's generative-AI device rulebook is still a draft, and the comment docket shuts October 19
Product · August 22, 2026 · 3 publishers
- Cyclosporiasis cases are easing, but one state's count is 95% of the national total
Science · August 21, 2026 · 1 publisher
- Enhanced Games' $62M quarter puts a price on buying legitimacy
Product · August 20, 2026 · 1 publisher
- Three Salmonella Outbreaks, One Failure Mode: Nobody Knew Where the Ingredient Went
Product · August 20, 2026 · 1 publisher
- 97% of the record menthol-ban comments were form letters, Rutgers audit of all 246,808 finds
Science · August 20, 2026 · 1 publisher
- Vivodyne says the AI drug bottleneck is human tissue data, not model capability
Product · August 19, 2026 · 1 publisher
- An FDA panel wants unapproved peptides sold by prescription. That is deregulation, not wellness.
Science · August 18, 2026 · 1 publisher
- COVID is growing in all 50 states, and the CDC said in June where it would start
Science · August 17, 2026 · 1 publisher